To test whether this phenotype is modifiable, we analyzed plasma samples from a 12-week trial of a medical ketogenic diet in 15 individuals with mild AD (n = 9 APOE ε4 carriers, n = 6 non-carriers; Supplementary Table 10). The gene discussed is APOE; the disease is Alzheimer disease.